Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AXYS Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (195)	12/14/1998 9:03:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 455

Oral active..... nice. I used to work for Bayer. You should see Leverkusen.... the Bayer plant is the city. Place is huge. Worms have been in the news, as a result of this...... biz.yahoo.com WSJ reporter Waldholz, who is quite good, was on CNBC today, talking up C. elegans. He mentioned INCY and MLNM, but not AXPH. This while AXPH is one of few companies that are working with the worms (Sequana acquired NemaPharm, 10/96) and which will be positioned to take advantage of the genome info.